Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.

Walsh CC, Landersdorfer CB, McIntosh MP, Peleg AY, Hirsch EB, Kirkpatrick CM, Bergen PJ.

J Antimicrob Chemother. 2016 Apr 26. pii: dkw115. [Epub ahead of print]

PMID:
27118778
2.

Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms.

Yang S, Hay ID, Cameron DR, Speir M, Cui B, Su F, Peleg AY, Lithgow T, Deighton MA, Qu Y.

Sci Rep. 2015 Dec 21;5:18578. doi: 10.1038/srep18578.

3.

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.

Jiang JH, Peleg AY.

Genes (Basel). 2015 Nov 30;6(4):1256-67. doi: 10.3390/genes6041256.

4.

Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.

Langan KM, Kotsimbos T, Peleg AY.

Curr Opin Infect Dis. 2015 Dec;28(6):547-56. doi: 10.1097/QCO.0000000000000217. Erratum in: Curr Opin Infect Dis. 2016 Feb;29(1):98.

PMID:
26524327
5.

Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology.

Kostoulias X, Murray GL, Cerqueira GM, Kong JB, Bantun F, Mylonakis E, Khoo CA, Peleg AY.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):161-7. doi: 10.1128/AAC.01540-15.

6.

Insights on virulence from the complete genome of Staphylococcus capitis.

Cameron DR, Jiang JH, Hassan KA, Elbourne LD, Tuck KL, Paulsen IT, Peleg AY.

Front Microbiol. 2015 Sep 23;6:980. doi: 10.3389/fmicb.2015.00980. eCollection 2015.

7.

Species identification within Acinetobacter calcoaceticus-baumannii complex using MALDI-TOF MS.

Toh BE, Paterson DL, Kamolvit W, Zowawi H, Kvaskoff D, Sidjabat H, Wailan A, Peleg AY, Huber CA.

J Microbiol Methods. 2015 Nov;118:128-32. doi: 10.1016/j.mimet.2015.09.006. Epub 2015 Sep 14.

PMID:
26381662
8.

The influence of bacterial interaction on the virulence of Cryptococcus neoformans.

Dhamgaye S, Murray GL, Peleg AY.

Virulence. 2015;6(7):677-8. doi: 10.1080/21505594.2015.1088632.

PMID:
26364987
9.

Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey.

Iraz M, Özad Düzgün A, Sandallı C, Doymaz MZ, Akkoyunlu Y, Saral A, Peleg AY, Özgümüş OB, Beriş FŞ, Karaoğlu H, Çopur Çiçek A.

Ann Lab Med. 2015 Nov;35(6):595-601. doi: 10.3343/alm.2015.35.6.595.

10.

Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.

Bæk KT, Thøgersen L, Mogenssen RG, Mellergaard M, Thomsen LE, Petersen A, Skov S, Cameron DR, Peleg AY, Frees D.

Antimicrob Agents Chemother. 2015 Nov;59(11):6983-91. doi: 10.1128/AAC.01303-15. Epub 2015 Aug 31.

11.

Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit.

Abbott IJ, Jenney AW, Spelman DW, Pilcher DV, Sidjabat HE, Richardson LJ, Paterson DL, Peleg AY.

Pathology. 2015 Oct;47(6):575-9. doi: 10.1097/PAT.0000000000000302.

PMID:
26308128
12.

Differentiation of Acinetobacter Genomic Species 13BJ/14TU from Acinetobacter haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).

Toh BE, Zowawi HM, Krizova L, Paterson DL, Kamolvit W, Peleg AY, Sidjabat H, Nemec A, Pflüger V, Huber CA.

J Clin Microbiol. 2015 Oct;53(10):3384-6. doi: 10.1128/JCM.03468-14. Epub 2015 Jul 29. No abstract available.

13.

In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.

Walsh CC, McIntosh MP, Peleg AY, Kirkpatrick CM, Bergen PJ.

J Antimicrob Chemother. 2015 Nov;70(11):3042-50. doi: 10.1093/jac/dkv221. Epub 2015 Jul 24.

PMID:
26209311
14.

Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens.

Rack JG, Morra R, Barkauskaite E, Kraehenbuehl R, Ariza A, Qu Y, Ortmayer M, Leidecker O, Cameron DR, Matic I, Peleg AY, Leys D, Traven A, Ahel I.

Mol Cell. 2015 Jul 16;59(2):309-20. doi: 10.1016/j.molcel.2015.06.013. Epub 2015 Jul 9.

15.

Draft Genome Sequences of Clinical Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strain APS211 and Its Daptomycin-Susceptible Progenitor APS210.

Cameron DR, Jiang JH, Abbott IJ, Spelman DW, Peleg AY.

Genome Announc. 2015 Jun 11;3(3). pii: e00568-15. doi: 10.1128/genomeA.00568-15.

16.

Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis.

Dexter C, Murray GL, Paulsen IT, Peleg AY.

Expert Rev Anti Infect Ther. 2015 May;13(5):567-73. doi: 10.1586/14787210.2015.1025055. Review.

PMID:
25850806
17.

Impact of daptomycin resistance on Staphylococcus aureus virulence.

Cameron DR, Mortin LI, Rubio A, Mylonakis E, Moellering RC Jr, Eliopoulos GM, Peleg AY.

Virulence. 2015;6(2):127-31. doi: 10.1080/21505594.2015.1011532.

18.

Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies.

Abbott IJ, Peleg AY.

Semin Respir Crit Care Med. 2015 Feb;36(1):99-110. doi: 10.1055/s-0034-1396929. Epub 2015 Feb 2. Review.

PMID:
25643274
19.

Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Doi Y, Murray GL, Peleg AY.

Semin Respir Crit Care Med. 2015 Feb;36(1):85-98. doi: 10.1055/s-0034-1398388. Epub 2015 Feb 2. Review.

20.

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.

Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL.

Trials. 2015 Jan 27;16:24. doi: 10.1186/s13063-014-0541-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk